SCHEMBL21472926

SCHEMBL21472926

N#Cc1ccc(-n2c3c(ccc4c3c3ccccc3n4-c3ccccc3)c3ccc4c(c5c(C#N)cccc5n4-c4ccccc4)c32)cc1

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.39
ATM Q13315 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
USP14 P54578 3/20 0.34
SLC22A12 Q96S37 1/20 0.32
IMPDH2 P12268 1/20 0.31
RPS6KB1 P23443 1/20 0.31
GSK3B P49841 1/20 0.31
G6PD P11413 1/20 0.30
MEN1 O00255 1/20 0.30
ALDH1A1 P00352 1/20 0.30
TSHR P16473 1/20 0.30
KMT2A Q03164 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30
TDP1 Q9NUW8 1/20 0.30
TDP2 O95551 1/20 0.30
PDE10A Q9Y233 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21472696 1.00 KDM4E (0.39) KDM4EATML3MBTL1USP14SLC22A12
SCHEMBL21472688 1.00 KDM4E (0.39) KDM4EATML3MBTL1USP14SLC22A12
SCHEMBL21472908 0.92 KDM4E (0.38) KDM4EATML3MBTL1USP14SLC22A12
SCHEMBL21472669 0.92 KDM4E (0.38) KDM4EATML3MBTL1USP14SLC22A12
SCHEMBL21472891 0.92 KDM4E (0.38) KDM4EATML3MBTL1USP14SLC22A12
SCHEMBL21472932 0.92 KDM4E (0.46) KDM4EATML3MBTL1USP14SLC22A12
SCHEMBL21472888 0.92 KDM4E (0.46) KDM4EATML3MBTL1USP14SLC22A12
SCHEMBL21472909 0.92 KDM4E (0.46) KDM4EATML3MBTL1USP14SLC22A12
SCHEMBL21472887 0.92 KDM4E (0.46) KDM4EATML3MBTL1USP14SLC22A12
SCHEMBL21472938 0.91 KDM4E (0.37) KDM4EATML3MBTL1RPS6KB1G6PD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11124521-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-09-21 US disclosed
US-20190315760-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMNITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2019-10-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11124521-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CRY2, CCNT1 KDM4E 2960/4885ATM 1582/4885L3MBTL1 958/4885
US-20190315760-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMNITTING DEVICE INCLUDING THE SAME CCNT1, CRY1, CCNT2 KDM4E 3323/4885ATM 1356/4885L3MBTL1 1498/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.